🏥 VAERS Vaccine Data Browser

🔒 Privacy & Data Disclaimer

About This Site

This is a public data browser for the Vaccine Adverse Event Reporting System (VAERS). By using this site, you acknowledge and agree to the following:

Data Source & Accuracy

  • Public Data: All data displayed comes from the publicly available VAERS database maintained by the CDC and FDA.
  • No Verification: VAERS accepts all reports without verifying medical accuracy. Reports do not prove causation between vaccines and adverse events.
  • Anyone Can Report: Healthcare providers, patients, family members, and anyone else can submit reports to VAERS.
  • Research Purpose: This data is for transparency, research, and monitoring vaccine safety signals only.

Your Privacy

  • No Personal Data Collection: This site does not collect, store, or track any personal information about visitors.
  • No Cookies: We do not use cookies except for remembering that you've seen this disclaimer (stored locally in your browser).
  • No Analytics: We do not use Google Analytics or any other tracking services.
  • Search Privacy: Your searches and filters are not logged or stored on our servers.
  • Public Data Only: The VAERS data shown here is already public and contains no personally identifiable information.

Medical Disclaimer

  • Not Medical Advice: This tool is for informational purposes only and does not provide medical advice.
  • Consult Healthcare Providers: Always consult qualified healthcare professionals for medical decisions.
  • No Liability: We are not responsible for decisions made based on this data.

Data Interpretation

  • The presence of a report does not mean the vaccine caused the adverse event.
  • Coincidental events are often reported (e.g., a heart attack that happened to occur after vaccination).
  • Serious adverse events must be reported by law, even if unrelated to the vaccine.
  • The database is useful for detecting safety signals that require further investigation.

📖 Help & Search Guide

Column Icons Legend

💀 Death
🏥 Hospitalized
🚑 Emergency Room
♿ Disability
⚠️ Life Threatening

How to Search

💡 Search Tips:
  • Select Year: Choose a specific year OR "All Years" to search across all data
  • All Years requires filters: When searching all years, you must select at least one filter (lot number, vaccine type, outcome, etc.) for performance
  • Lot number tracking: Use "All Years" + Lot Number to track lots across multiple years
  • Combine filters: Use multiple filters together to narrow results (e.g., Age + Vaccine Type + Death)
  • VAERS ID: Search for specific report by ID number
  • Age: Enter exact age (e.g., 25) or decimal (e.g., 0.5 for 6 months)
  • State: Enter 2-letter state code (e.g., CA, NY, TX)
  • Vaccine Type: Search partial names (e.g., "COVID19", "FLU", "HPV")
  • Manufacturer: Search by company (e.g., "PFIZER", "MODERNA")
  • Lot Number: Search specific vaccine lot (works great with "All Years")
  • Symptoms: Search for any symptom keyword (e.g., "fever", "rash")
  • Death/Hospitalized: Filter to only show cases with these outcomes

Understanding the Data

  • Reports are unverified: VAERS accepts all reports without medical verification
  • Not proof of causation: A report does not mean the vaccine caused the event
  • Anyone can report: Healthcare providers, patients, and family members can submit reports
  • Multiple vaccines: One report may list multiple vaccines given at the same time
  • Blank fields: Not all fields are required, so some data may be missing

Using the Table

  • Sort columns: Click column headers (ID, Age, Sex, Date, Died) to sort
  • Expand text: Click "More" to see full narrative or symptom text
  • Navigate pages: Use pagination controls at top and bottom of table
  • Export results: Click "📥 Export CSV" to download filtered data (max 10,000 records)

💡 Frequently Asked Questions (FAQ)

What is this site?

🏥 VAERS Vaccine Data Browser is an independent, third-party data browser for publicly available VAERS (Vaccine Adverse Event Reporting System) data.

Important: This site is NOT affiliated with, endorsed by, or operated by the CDC, FDA, or any government agency. We are an independent service that makes public VAERS data easier to search and analyze.

What is VAERS?

VAERS (Vaccine Adverse Event Reporting System) is a national early warning system established in 1990 to detect possible safety problems with vaccines. It's co-managed by the CDC (Centers for Disease Control and Prevention) and FDA (Food and Drug Administration).

VAERS accepts and analyzes reports of adverse events (possible side effects) after a person has received a vaccination.

Official VAERS website: vaers.hhs.gov

Is this data HIPAA compliant?

Yes, absolutely. All VAERS data displayed here is:

  • Publicly available - Published by the CDC/FDA on their official website
  • De-identified - Contains no personally identifiable information (names, addresses, contact info removed)
  • Legally accessible - Available to researchers, media, and the general public under FOIA (Freedom of Information Act)
  • Not protected health information - Once de-identified and published by the government, it's no longer covered by HIPAA restrictions

This site displays the same public data available at vaers.hhs.gov/data.

Why does this site exist?

We believe in transparency and public access to health data. While the CDC/FDA provide VAERS data, their official site:

  • Is difficult to search and filter
  • Requires downloading large CSV files and technical knowledge
  • Is not user-friendly for the average person

This independent site makes the same publicly available data easier to search, filter, and understand for researchers, journalists, healthcare workers, and concerned citizens.

Where does the data come from?

All data is downloaded directly from the official CDC/FDA VAERS website at vaers.hhs.gov/data.

The data is:

  • Publicly released by the CDC/FDA every week
  • Available as downloadable CSV files
  • Imported into this site's database for easier searching
  • Displayed exactly as provided (no modifications or filtering)

This site does not collect, modify, or add to the official VAERS data.

My vaccine lot number matches one with deaths/serious events - should I be worried?

Important context:

  • VAERS reports do NOT prove causation - A report means an event occurred after vaccination, but doesn't mean the vaccine caused it
  • Anyone can report - Reports are not verified for medical accuracy before being published
  • Coincidences happen - When millions of people get vaccinated, some will experience unrelated medical events afterward
  • Large lot numbers - Popular vaccines may have hundreds of thousands of doses from one lot number
  • More vaccinations = more reports - Lots used widely will naturally have more reports

What to do:

  • Don't panic - VAERS data requires expert analysis to interpret
  • Talk to your doctor if you have concerns
  • Check official CDC/FDA safety communications for genuine safety signals
  • Remember: billions of vaccine doses have been safely administered

Can I trust VAERS data?

VAERS is valuable but has limitations:

Strengths:

  • ✅ Early warning system for potential safety signals
  • ✅ Open and transparent - publicly accessible
  • ✅ Accepts all reports regardless of likelihood of causation
  • ✅ Monitored by CDC/FDA experts who investigate concerning patterns

Limitations:

  • ⚠️ Reports are unverified - not investigated before publication
  • ⚠️ Cannot determine if vaccine caused the event
  • ⚠️ Underreporting - not all adverse events are reported
  • ⚠️ Overreporting - coincidental events may be reported
  • ⚠️ Incomplete data - not all fields are required

Bottom line: VAERS is an important tool for safety monitoring, but individual reports should not be used as proof that a vaccine caused harm.

What are "adverse events"?

An adverse event is any undesirable health occurrence that happens after vaccination, including:

  • Common reactions: Sore arm, mild fever, fatigue (usually expected)
  • Serious events: Hospitalization, disability, life-threatening illness, death
  • Coincidental events: Medical conditions that would have occurred anyway

Important: An adverse event doesn't mean the vaccine caused it - only that it occurred after vaccination. Many reported events are coincidental or unrelated.

Why are some lot numbers listed multiple times?

This is normal and expected! A person may receive multiple doses of the same vaccine from the same lot number:

  • COVID vaccines require 2-3 doses
  • HPV, Hepatitis B, and other vaccines have multi-dose schedules
  • Each dose is recorded as a separate entry

Example: Person receives Pfizer COVID dose 1 (lot ABC123) and dose 2 (lot ABC123) - lot ABC123 appears twice in their report.

How often is this data updated?

The CDC/FDA releases new VAERS data every Friday. This site is typically updated:

  • Weekly or bi-weekly for recent data
  • Check the available years to see what data is currently loaded
  • During updates, the site may be in maintenance mode temporarily

Where can I learn more?

⚠️ DISCLAIMER: This data is from the Vaccine Adverse Event Reporting System (VAERS). Reports do not establish causation between vaccines and adverse events. Anyone can submit a report, and reports are not verified. This is raw data for transparency and research purposes only.
34,052
Total Reports (2025)
500
Deaths Reported
1,634
Hospitalizations
30
ER Visits
1,191
Disabilities
570
Life Threatening
🔄 Reset 📥 Export CSV
ID Age Sex State Date ▼ Onset Days Vaccine Manufacturer Lot # Symptoms Narrative 💀 🏥 🚑 ♿ ⚠️
2794661 0.5 M NY 09/30/2024 COVID19
COVID19
DTPPVHBHPB
PNC20
RV5
 PFIZER\BIONTECH
PFIZER\BIONTECH
MSP VACCINE COMPANY
PFIZER\WYETH
MERCK & CO. INC.
 LN8272
LN8272
U7296AA
LC1279
Y011480
Incorrect dose administered, No adverse event; Incorrect dose administered, Irri... Incorrect dose administered, No adverse event; Incorrect dose administered, Irritability, Pyrexia; Incorrect dose administered, Irritability, Pyrexia; Incorrect dose administered, Irritability, Pyrexia; Incorrect dose administered, Irritability, Pyrexia More
No adverse symptoms reported. 1.1 mL of the diluted Covid vaccine was administered to patient instea... No adverse symptoms reported. 1.1 mL of the diluted Covid vaccine was administered to patient instead of the ordered 0.3 mL. More
2824599 59 F FL 02/04/2025 TDAP
 GLAXOSMITHKLINE BIOLOGICALS
 3zh27
Inappropriate schedule of product administration, No adverse event Inappropriate schedule of product administration, No adverse event
The patient received another dose of Boostrix in less than a 1-year time frame. The patient does not... The patient received another dose of Boostrix in less than a 1-year time frame. The patient does not have any symptoms or side effects. She got a vaccine in June of 2024 and again yesterday, 2/4/25. More
2824600 75 F GA 02/04/2025 RSV
 GLAXOSMITHKLINE BIOLOGICALS
 52z52
Extra dose administered, No adverse event Extra dose administered, No adverse event
Duplicate administration. Previously administered 11/2023. No reported ADR. Reported to patient who ... Duplicate administration. Previously administered 11/2023. No reported ADR. Reported to patient who denies knowledge of previous administration. More
2824601 78 M GA 02/04/2025 RSV
 GLAXOSMITHKLINE BIOLOGICALS
 52z52
Extra dose administered Extra dose administered
No ADR. Duplicate vaccine. Previously administered in 11/2023. Pt denied knowledge of previous vacci... No ADR. Duplicate vaccine. Previously administered in 11/2023. Pt denied knowledge of previous vaccination. More
2824602 54 F AL 02/04/2025 PNC21
PNC21
 MERCK & CO. INC.
MERCK & CO. INC.
 Y013009
Y013009
Blister, Blister rupture, Hypersensitivity, Injection site pain, Pruritus; Pyrex... Blister, Blister rupture, Hypersensitivity, Injection site pain, Pruritus; Pyrexia, Swelling face More
Patient called the pharmacy 2 days post vaccine of Capvaxive. Patient was inquiring about possible s... Patient called the pharmacy 2 days post vaccine of Capvaxive. Patient was inquiring about possible side effects. Patient explained that she was itching all over with swelling of the face. Patient also stated she had blisters arise on her hands and legs that have since ruptured due to itching. Patient stated she had a low grade fever with injection site pain. Patient clarified she DID NOT have any difficulty breathing at the moment. RPH on staff explained that what she was experiencing describes an allergic reaction and directed her to take benadryl (diphenhydramine). Pharmacist emphasized to seek emergency help if difficulty breathing or altered mental state occurs. Patient verified understanding. More
2824603 78 F CO 02/04/2025 PNC20
 PFIZER\WYETH
 LG5577
Rash Rash
PT STATED SHE HAD A LOCAL RASH (NOT RAISED) and rash on her torso, inner upper right thigh. pt said... PT STATED SHE HAD A LOCAL RASH (NOT RAISED) and rash on her torso, inner upper right thigh. pt said it was not itchy. More
2824604 67 M FL 02/04/2025 RSV
 GLAXOSMITHKLINE BIOLOGICALS
 255t2
Extra dose administered, No adverse event Extra dose administered, No adverse event
Patient was given a second dose of RSV (Arexvy) vaccine. Patient stated no side effects. Patient was given a second dose of RSV (Arexvy) vaccine. Patient stated no side effects.
2824605 59 M OH 02/04/2025 UNK
UNK
 UNKNOWN MANUFACTURER
UNKNOWN MANUFACTURER

Asthenia, Ear discomfort, Impaired work ability, Myalgia, Nasal congestion; Pain... Asthenia, Ear discomfort, Impaired work ability, Myalgia, Nasal congestion; Pain, Pain in extremity More
Arm pain 2 days, muscle aches, nasal congestion, ears plugged, weakness and pain after exercising 5 ... Arm pain 2 days, muscle aches, nasal congestion, ears plugged, weakness and pain after exercising 5 days and still running. Missed work. More
2824606 66 F FL 02/04/2025 RSV
 GLAXOSMITHKLINE BIOLOGICALS
 255t2
Extra dose administered, No adverse event Extra dose administered, No adverse event
Patient was given a second dose of RSV (Arexvy); had previously received in 2023. Patient stated no ... Patient was given a second dose of RSV (Arexvy); had previously received in 2023. Patient stated no side effects. More
2824607 50 F SC 02/04/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 7zm55
Peripheral swelling Peripheral swelling
Patient received shingrix shot Monday Feb 3 and woke up Tuesday Feb 4 to swollen hand on the same si... Patient received shingrix shot Monday Feb 3 and woke up Tuesday Feb 4 to swollen hand on the same side she received vaccine. No swelling in arm or at injection site, just swollen hand. More
2824608 50 F WA 02/04/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
Abdominal discomfort, Erythema, Inflammation, Myalgia, Pyrexia Abdominal discomfort, Erythema, Inflammation, Myalgia, Pyrexia
Arm was red from my shoulder to my elbow, and was inflamed. I had incredible muscle aches, fever, an... Arm was red from my shoulder to my elbow, and was inflamed. I had incredible muscle aches, fever, and was sick to my stomach for 5 -7 days More
2824117 U IL 02/03/2025 MMRV
 MERCK & CO. INC.
 Y010050
No adverse event, Product storage error No adverse event, Product storage error
No symptomatic adverse events were reported.; HCP called to report a Temperature Excursion on case ... No symptomatic adverse events were reported.; HCP called to report a Temperature Excursion on case number 02740636. The case is still ongoing and it could not be confirmed if the products were still supported. The HCP reports that PROPQUAD was inadvertently administered after suffering from a T; This spontaneous report was received from a registered nurse (RN) concerning to a patient of unspecified age and gender. The patient's medical history, concurrent conditions and drug reactions/allergies were not reported. Concomitant medications included sterile diluent (MERCK STERILE DILUENT) (reported as "Diluent MRK".) On 09-JAN-2025, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live recombinant Human Albumin (rHA) (PROQUAD) injection, 0.5ml/series, lot #Y010050, expiration date 25-NOV-2025 (dosage regimen, anatomical location and route of administration were not provided) administered as prophylaxis. The vaccine was inadvertently administered after suffering from a temperature excursion (product storage error.) It was reported that the product reached -11.6 degrees Celsius (c) and was out of range for 3 hours 5 minutes 0 seconds. Previous excursions could not be confirmed and at the reporting time, temperature excursion was ongoing and it was not possible to confirm if the products were still supported. No symptomatic adverse events were reported (no adverse event). No additional information available. This was one of several reports received from the same reporter.; Sender's Comments: US-009507513-2501USA007066: US-009507513-2501USA008866: US-009507513-2501USA008885: US-009507513-2501USA008880: US-009507513-2501USA008935: US-009507513-2501USA008877: US-009507513-2501USA008882: US-009507513-2501USA007047: US-009507513-2501USA007446: US-009507513-2501USA008861: More
2824118 14 F IN 02/03/2025 MMRV
 MERCK & CO. INC.
 Y012077
No adverse event, Product administered to patient of inappropriate age No adverse event, Product administered to patient of inappropriate age
HCP calling to report an AE regarding the PROQUAD vaccine. HCP reported that a 14 year old female pa... HCP calling to report an AE regarding the PROQUAD vaccine. HCP reported that a 14 year old female patient was administered a dose of the PROQUAD vaccine. HCP did not report any side effects from the administration of the PROQUAD vaccine. HCP did not; HCP did not report any side effects from the administration of the PROQUAD vaccine.; This spontaneous report was received from registered nurse (RN) concerning to a 14-year-old female patient. Her medical history, concurrent conditions, concomitant therapies, and drug reactions/allergies were not reported. On an unknown date, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live recombinant Human Albumin (rHA) (PROQUAD) injection, lot #Y012077, expiration date 05-JAN-2026 (exact dose, dosage regimen, anatomical location and route of administration were not provided) administered as prophylaxis (product administered to patient of inappropriate age.) The reporter did not inform any side effects from the administration of the measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) vaccine (no adverse event), did not state the reason for the administration of the vaccine and provided limited pertinent information and demographic data. More
2824120 U MO 02/03/2025 MMR
 MERCK & CO. INC.
 X026222
Device connection issue, No adverse event Device connection issue, No adverse event
No additional AE; Nurse called to report that the needle "popped off" a prefilled DILUENT ... No additional AE; Nurse called to report that the needle "popped off" a prefilled DILUENT syringe after it was used to administer a dose of MMR II.; Nurse called to report that the needle "popped off" a prefilled DILUENT syringe after it was used to administer a dose of MMR II.; Nurse called to report that the needle "popped off" a prefilled DILUENT syringe after it was used to administer a dose of MMR II.; This spontaneous report was received from nurse and refers to a patient of an unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 21-JAN-2025, the patient was vaccinated with sterile diluent (BAXTER STERILE DILUENT) solution for injection/infusion, unk, valid lot #1973259, expiration date: 03-MAR-2026 (strength, route of administration, and indication were not provided); and measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) injection, unk, valid lot #X026222, expiration date: 06-NOV-2025, administered for prophylaxis (strength, and route of administration were not provided). The reporter stated that the needle popped off a diluent syringe after it was used to administered a vaccine. The problem occurred when the staff member tried to engage the safety on the needle and it instead came off the syringe and caused a needle stick in the staff member left hand (needle issue, device connection issue and poor quality device used). The reporter stated that the patient received full dose and no issue was noted prior to or during administration. The reporter stated that no patient symptoms have been reported. No additional adverse event (AE) was reported. More
2824121 U TX 02/03/2025 HPV9
 MERCK & CO. INC.
 W029724
Expired product administered, No adverse event Expired product administered, No adverse event
No additional AE; Medical Assistant called to report expired GARDASIL 9 administered to a patient.; ... No additional AE; Medical Assistant called to report expired GARDASIL 9 administered to a patient.; This spontaneous report was received from medical assistant and refers to a patient of an unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 29-JAN-2025, the patient was vaccinatedwith hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, 0.5 milliliter, valid lot #W029724, expiration date: 08-JAN-2025, administered for prophylaxis (strength, and route of administration were not provided) (expired product administered). No symptoms reported. No additional adverse event (AE). More
2824122 1 U NH 02/03/2025 MMRV
VARCEL
 MERCK & CO. INC.
MERCK & CO. INC.
 Y011215
X028613
Extra dose administered, No adverse event; Extra dose administered, No adverse e... Extra dose administered, No adverse event; Extra dose administered, No adverse event More
No events were reported; Nurse calling to report that a dose of VARIVAX and PROQUAD were administere... No events were reported; Nurse calling to report that a dose of VARIVAX and PROQUAD were administered concomitantly to a 1 year old patient. No clinical events were reported. No PQC. No additional information.; This spontaneous report was received from a registered nurse referring to a 1 year old patient of unknown gender. The patient's pertinent medical history, concurrent conditions, drug reactions or allergies, and concomitant therapies were not reported. On 21-JAN-2025, the patient was vaccinated with a dose of varicella virus vaccine live (oka/merck)(VARIVAX) lot # X028613, expiration date: 13-DEC-2025 (strength, dose, dose number, route and anatomical location were not provided) for prophylaxis concomitantly with a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) # Y011215, expiration date: 18-DEC-2025 (strength, dose, dose number, route and anatomical location were not provided) for prophylaxis . No clinical events were reported. More
2824123 U MO 02/03/2025 PPV
 MERCK & CO. INC.
 X018273
Expired product administered Expired product administered
No additional AE/PQC reported; Medical Assistant calling with a report of an adverse event regarding... No additional AE/PQC reported; Medical Assistant calling with a report of an adverse event regarding an expired dose of PNEUMOVAX 23 that was administered to a patient.; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 30-JAN-2025, the patient was vaccinated with an expired dose of pneumococcal 23v polysaccharide vaccine (PNEUMOVAX23) injection, 0.5 milliliter, lot #X018273, expiration date: 07-OCT-2024, administered for prophylaxis (strength, and route of administration were not provided) (Expired product administered). Medical Assistant confirmed the patient involved had not had any medical concerns or symptoms after the administration of the expired dose of the vaccine. More
2824124 U IL 02/03/2025 MMRV
 MERCK & CO. INC.
 Y010050
Product storage error Product storage error
Customer calling to report temperature excursion. PROQUAD dose was administered on 1/23/2025. No PQC... Customer calling to report temperature excursion. PROQUAD dose was administered on 1/23/2025. No PQC. No additional information.; This spontaneous report was received from a nurse and and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 23-JAN-2025, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant Human albumin (rHA) (PROQUAD) injection, 0.5 milliliter, lot #Y010050, expiration date: 25-NOV-2025, administered for prophylaxis (strength, and route of administration were not provided). On 23-JAN-2025, the patient experienced Customer calling to report temperature excursion (Product storage error ). PROQUAD dose was administered on 1/23/2025. No PQC. No additional information.. At the time of reporting, the outcome of the event Customer calling to report temperature excursion. PROQUAD dose was administered on 1/23/2025. No PQC. No additional information. was not known. The action taken with PROQUAD regarding Customer calling to report temperature excursion. PROQUAD dose was administered on 1/23/2025. No PQC. No additional information. was reported as Not Applicable. More
2824125 U IL 02/03/2025 MMRV
 MERCK & CO. INC.
 Y010050
Product storage error Product storage error
Customer calling to report temperature excursion. PROQUAD dose was administered on 1/29/2025. No PQC... Customer calling to report temperature excursion. PROQUAD dose was administered on 1/29/2025. No PQC. No additional information.; This spontaneous report was received from registered Nurse referred to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 29-JAN-2025, the patient started therapy with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) injection, 0.5 milliliter, lot #Y010050, expiration date: 25-NOV-2025, administered for prophylaxis (strength, dose number, frequency, scheme, route of administration, and anatomical location were not reported). The vaccine underwent a temperature excursion (Improper storage of product in use). The duration of temperature excursion, and if there were previous temperature excursions were not reported. More
2824126 12 F 02/03/2025 HPV9
 MERCK & CO. INC.
 X024251
Conversion disorder, Syncope Conversion disorder, Syncope
diagnosed with functional neurological disorder/Doctors are saying the fainting is the result of thi... diagnosed with functional neurological disorder/Doctors are saying the fainting is the result of this diagnosis; toothache; Drug reactions: AMOXYCILLIN/she broke out in hives; This spontaneous report was received from the patient's mother regarding her approximately 13-year-old daughter (female). The patient's medical history was not reported. Historical drugs included lurasidone hydrochloride (LATUDA). The patient's concurrent conditions included seasonal allergy and allergy to lurasidone hydrochloride (LATUDA). Concomitant medications included aripiprazole (ABILIFY) and topiramate (reported as ''topirmate''). On 08-NOV-2024, the patient was vaccinated with the second dos of human papilloma virus (HPV) rL1 6 11 16 18 31 33 45 52 58 virus like particle (VLP) vaccine (yeast) (GARDASIL 9) injection, lot #X024251 (expiration date was not provided but upon validation it was found to be 15-MAY-2026), administered intramuscularly to prevent HPV (strength was not provided). On an unknown date, the patient started therapy with amoxicillin, administered for toothache (strength, formulation, dose, lot #, expiry date, and route of administration were not provided). After which she broke out in hives On an unknown date (after the second dose of the suspect vaccine), the patient began to experience side effects with the suspect vaccine, such as fainting, that was later diagnosed as functional neurological disorder (Conversion disorder), as the doctors thought was the cause of fainting. Therefore, the patient was admitted to the hospital (date of admission not reported), to seek medical attention, but no treatment was given for this event. The action taken with amoxicillin regarding the events was not reported. At the time of this report the patient ad not recovered from conversion disorder; the outcome of the remaining events was not provided. The causal relationship between amoxicillin and hives was not reported, but given wording and company guidelines it was considered as related; the causality between this suspect drug and toothache was considered as not related; and for conversion disorder was not reported. The causal relationship between HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) and all the events was not provided. More
✓
2824127 U IN 02/03/2025 HEPA
 MERCK & CO. INC.
 Y007585
No adverse event, Product storage error No adverse event, Product storage error
administered after temperature excursions; no adverse event; This spontaneous report was received fr... administered after temperature excursions; no adverse event; This spontaneous report was received from Other Health Professional and refers to a currently 22-month-old patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On an unknown date, the patient started therapy with an improperly stored dose of hepatitis a vaccine, inactivated (VAQTA) intramuscular injection, lot #Y007585, expiration date: 31-OCT-2025, administered for prophylaxis (strength, dose, dose number, frequency, scheme, anatomical location, and route of administration were not provided) (Improper storage of product in use). The vaccine underwent a temperature excursion during 1h 30 m under 60 Fahrenheit Degrees. No previous temperature excursions. No adverse event reported. This case was previously reported as non-valid due to lack of individual patient identifiers, but upon follow-up information on 17-JAN-2025, was updated to valid. This case was one of three from the same reporter. ; Sender Comments: Keywords : MUL US-009507513-2502USA000139:Original Case : 2501USA004754 US-009507513-2501USA004754:Original Case : 2501USA004754 More
2824128 U IN 02/03/2025 HIBV
RV5
 MERCK & CO. INC.
MERCK & CO. INC.
 y003145
2052020
No adverse event, Product storage error; No adverse event, Product storage error No adverse event, Product storage error; No adverse event, Product storage error
administered after temperature excursions; no adverse event; This spontaneous report was received fr... administered after temperature excursions; no adverse event; This spontaneous report was received from Other Health Professional and refers to a currently 3-months-old patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On an unknown date, the patient started therapy with an improperly stored dose of haemophilus b conjugate vaccine (meningococcal protein conjugate)(LIQUID PEDVAXHIB) lot # y003145, expiration date: 12-SEP-2026, administered for prophylaxis (strength, dose, dose number, frequency, scheme, anatomical location, and route of administration were not provided); and on an unknown date, the patient started therapy with an improperly stored dose of rotavirus vaccine, live, oral, pentavalent(ROTATEQ) lot # 2052020, expiration date: 10-MAR-2026, administered orally for prophylaxis (strength, dose, dose number, frequency, and scheme were not provided); (Improper storage of product in use). The vaccine underwent a temperature excursion during 1h 30 m under 60 Fahrenheit Degrees. No previous temperature excursions. No adverse event reported. This case was previously reported as non-valid due to lack of individual patient identifiers, but upon follow-up information on 17-JAN-2025, was updated to valid. This case was one of three from the same reporter. ; Sender's Comments: US-009507513-2501USA004754:Original Case : 2501USA004754 US-009507513-2502USA000138:Original Case : 2501USA004754 More
2824129 M MD 02/03/2025 HPV9
 MERCK & CO. INC.
Inappropriate schedule of product administration, No adverse event Inappropriate schedule of product administration, No adverse event
No additional AE; Patient received the first dose on October 19, 2023 and the second dose in the ser... No additional AE; Patient received the first dose on October 19, 2023 and the second dose in the series on 12/20/2024.; This spontaneous report was received from a registered pharmacist and refers to a 28-year-old male patient. No information regarding the patient's medical history, concurrent conditions, concomitant medication, drug reactions or allergies was provided. On 19-OCT-2023, the patient was vaccinated with the first dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) 0.5 milliliter (lot #, expiration date, route and site of administration were not reported) for prophylaxis. On 20-DEC-2024, he received the second dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) 0.5 milliliter (lot #, expiration date, route and site of administration were not reported) for prophylaxis (Inappropriate schedule of product administration). No additional adverse event was reported. More
2824130 0.17 U CO 02/03/2025 VARCEL
 MERCK & CO. INC.
 Y011712
No adverse event, Product administered to patient of inappropriate age, Product ... No adverse event, Product administered to patient of inappropriate age, Product storage error More
2 month old patient was administered a dose of VARIVAX on 11/8/2024 "due to an error in their v... 2 month old patient was administered a dose of VARIVAX on 11/8/2024 "due to an error in their vaccine storage".; No additional AE; 2 month old patient was administered a dose of VARIVAX on 11/8/2024 "due to an error in their vaccine storage".; This spontaneous report was received from a physician assistant via an office manager and refers to a 2-month-old patient of an unknown gender. No information regarding the patient's medical history, concurrent conditions, concomitant medications, drug reactions or allergies was provided. On 08-NOV-2024 at the age of 2 months, the patient was vaccinated with varicella virus vaccine live (Oka/Merck) (VARIVAX) 0.5 milliliter, lot # Y011712 was confirmed to be valid, expiration date 02-JUL-2026 (route and site of administration were not provided) for prophylaxis, due to error in vaccine storage (Product administered to patient of inappropriate age, Product storage error). It was confirmed that the patient did not experience any medical concerns or symptoms. No additional adverse event reported. More
2824131 U 02/03/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 UNK
Herpes zoster, Vaccination failure Herpes zoster, Vaccination failure
Suspected vaccination failure; got shingles; This serious case was reported by a consumer via intera... Suspected vaccination failure; got shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: got shingles). The outcome of the vaccination failure was not reported and the outcome of the shingles was resolved. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix. The company considered the vaccination failure and shingles to be unrelated to Shingrix. Additional Information: GSK Receipt Date: 19-JAN-2025 The reporter reported that did not stress at all was a way not to get them and no vaccines. The number one cause of it everyone he/she know get the Shingrix shot and they got Shingles. Just like Covid vaccines all got Covid and it was bad Covid vaccine was to bring on the virus and did that makes no sense. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting.; Sender's Comments: Vaccination failure is a listed event which, due to the following criteria (insufficient information provided about the clinical description, details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of disease) is considered unrelated to GSK vaccine Shingrix. Herpes zoster is an unlisted event which is considered unrelated to GSK vaccine Shingrix. More
2824132 F CT 02/03/2025 HEPAB
 GLAXOSMITHKLINE BIOLOGICALS
 UNK
Incomplete course of vaccination Incomplete course of vaccination
got her 1st dose of Twinrix on 7/1/2024...she is scheduled coming today; This non-serious case was r... got her 1st dose of Twinrix on 7/1/2024...she is scheduled coming today; This non-serious case was reported by a nurse via call center representative and described the occurrence of incomplete course of vaccination in a female patient who received HAB (Twinrix) for prophylaxis. Previously administered products included Twinrix (received 1st dose on 01-JUL-2024, batch number:H7RF72 and expiry date:17-JAN-2026). On an unknown date, the patient did not receive the 2nd dose of Twinrix. On an unknown date, an unknown time after receiving Twinrix, the patient experienced incomplete course of vaccination (Verbatim: got her 1st dose of Twinrix on 7/1/2024...she is scheduled coming today). The outcome of the incomplete course of vaccination was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 07-JAN-2025 The reporter called to inform that they had a patient, she got her 1st dose of Twinrix on 7th January 2024 and she was scheduled coming at the time of reporting for the 2nd dose, she's long overdue. Did not consent to follow-up. Till the time of reporting, the patient did not receive the 2nd dose of Twinrix, which led to incomplete course of vaccination. More
2824133 F NJ 02/03/2025 HEPA
 GLAXOSMITHKLINE BIOLOGICALS
 55M72
Expired product administered Expired product administered
received an expired dose of Havrix; This non-serious case was reported by a physician via call cente... received an expired dose of Havrix; This non-serious case was reported by a physician via call center representative and described the occurrence of expired vaccine used in a 22-year-old female patient who received HAV (Havrix) (batch number 55M72, expiry date 13-DEC-2024) for prophylaxis. On 07-JAN-2025, the patient received the 1st dose of Havrix. On 07-JAN-2025, an unknown time after receiving Havrix, the patient experienced expired vaccine used (Verbatim: received an expired dose of Havrix). The outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 07-JAN-2025 Reporter explained that a patient received an expired dose of Havrix on January 7th 2025 and vaccine was expired on December 13th 2024 which led to expired vaccine used. It was the first dose of a Hepatitis A vaccine for the patient. More
2824134 48 F MI 02/03/2025 MMR
 GLAXOSMITHKLINE BIOLOGICALS
 342rc
Incorrect route of product administration Incorrect route of product administration
Priorix intramuscular route instead of subcutaneous route; This non-serious case was reported by a n... Priorix intramuscular route instead of subcutaneous route; This non-serious case was reported by a nurse via call center representative and described the occurrence of subcutaneous injection formulation administered by other route in a 48-year-old female patient who received MMR (Priorix) (batch number 342rc, expiry date 01-MAY-2025) for prophylaxis. On 09-JAN-2025, the patient received Priorix (intramuscular). On 09-JAN-2025, an unknown time after receiving Priorix, the patient experienced subcutaneous injection formulation administered by other route (Verbatim: Priorix intramuscular route instead of subcutaneous route). The outcome of the subcutaneous injection formulation administered by other route was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 09-JAN-2025 The reporter reported that a staff member gave Priorix intramuscular route instead of subcutaneous route at the time of reporting, which led to subcutaneous injection formulation administered by other route. The reporter consented to follow up. More
2824135 F CO 02/03/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 UNK
Incomplete course of vaccination Incomplete course of vaccination
incomplete course of vaccination; This non-serious case was reported by a consumer via call center r... incomplete course of vaccination; This non-serious case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a 73-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. The patient's past medical history included brain injury. Previously administered products included Shingrix (Patient received first dose couple of years ago). On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: incomplete course of vaccination). The outcome of the incomplete course of vaccination was unknown. Additional Information: GSK Receipt Date: 09-JAN-2025 The patient received the first dose of Shingrix a couple of years ago, and not yet received the second dose, which led to incomplete course of vaccination. More
2824136 78 F OH 02/03/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 94SE2
Incorrect dose administered Incorrect dose administered
Incomplete dose/some came out of it; This non-serious case was reported by a other health profession... Incomplete dose/some came out of it; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incomplete dose administered in a 78-year-old female patient who received Herpes zoster (Shingrix) (batch number 94SE2, expiry date 09-AUG-2026) for prophylaxis. On 15-JAN-2025, the patient received the 1st dose of Shingrix. On 15-JAN-2025, an unknown time after receiving Shingrix, the patient experienced incomplete dose administered (Verbatim: Incomplete dose/some came out of it). The outcome of the incomplete dose administered was unknown. Additional Information: GSK Receipt Date: 15-JAN-2025 A pharmacy intern called to inform that a patient came for her 1st dose of the Shingrix vaccine and when it was being administered, there was an issue with the syringe, and some came out of it, which led to incomplete dose administered. According to the reported, that happened earlier that day. The Vaccine Administration Facility was the same as Primary Reporter. The reporter consented to follow up. More
2824137 0.25 F NH 02/03/2025 DTAPIPVHIB
 SANOFI PASTEUR
 UK022AA
Product preparation issue Product preparation issue
she administered the pentacel to a patient, but when she administered it, she only gave the diluent ... she administered the pentacel to a patient, but when she administered it, she only gave the diluent with no reported adverse event; Initial information received on 30-Jan-2025 regarding an unsolicited valid non-serious case received from a Other health professional. This case involves, a 3 months old female patient who was administered the Diphtheria/Tetanus/5 Hybrid AC Pertussis/IPV(VERO)/HIB(PRP/T) Vaccine [Pentacel], but when she administered it, she only gave the diluent with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included Hepatitis B Vaccine (HEP B VAX); Pneumococcal Vaccine and Rotavirus Vaccine for Immunization. On 17-Jan-2025, the patient was administered 0.5 ml dose of the (Standard) Diphtheria/Tetanus/5 Hybrid AC Pertussis/IPV(VERO)/HIB(PRP/T) Vaccine (once) (lot UK022AA, expiry date: 30-Apr-2025) (unknown route) in the right thigh for immunization, but when she administered it, she only gave the diluent with no reported adverse event (single component of a two-component product administered) (latency-same day). Reportedly, The MA (Medical Assistant) did not mix it with the compound. The patient didn't get that part of the vaccine. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. More
2824143 50 F KY 02/03/2025 VARZOS
VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS

Nasal discomfort, Pain in extremity, Pyrexia, Rhinorrhoea, Skin warm; Sneezing Nasal discomfort, Pain in extremity, Pyrexia, Rhinorrhoea, Skin warm; Sneezing
Arm remains extremely sore and hot to touch on Day 5. Started with runny nose yesterday (day 4). Aw... Arm remains extremely sore and hot to touch on Day 5. Started with runny nose yesterday (day 4). Awoke a 2am this morning (day 5) with sneezing every few minutes. Inside nose/sinus is irritated with constant thin discharge from left nostril (clear, thin). Irregular low grade fever since late evening day 1. Symptoms ongoing. Annoying but no life threat. Symptoms lasting longer than published information, with new ones presenting. Treating with Tylenol, advil, ice to site and rest. More
2824146 U 02/03/2025 VARZOS
 UNKNOWN MANUFACTURER
 UNK
Malaise Malaise
the first made me feel sick for a few days; This non-serious case was reported by a consumer via int... the first made me feel sick for a few days; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of sickness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced sickness (Verbatim: the first made me feel sick for a few days). The outcome of the sickness was resolved. The reporter considered the sickness to be related to Shingles vaccine. The company considered the sickness to be related to Shingles vaccine. Additional Information: GSK receipt date: 18-JAN-2025 This case was reported by a patient via interactive digital media. The patient reported that he/she just got his/her second vaccine yesterday (day before reporting). The reporter mentioned that first vaccine made him/her feel sick for a few days. The reporter hoping this one was not as bad but, he/she was sure the side effects were a drop in the bucket compared to shingles. The patient mentioned that the thought of getting shingles was terrifying. More
2824150 39 F MT 02/03/2025 FLU3
 SANOFI PASTEUR
 QFAA1815
Erythema multiforme, Rash Erythema multiforme, Rash
Reported Symptoms: 1015218:ERYTHEMA MULTIFORME; 10037844:RASH; Narrative: Other Relevant HX: Other: Reported Symptoms: 1015218:ERYTHEMA MULTIFORME; 10037844:RASH; Narrative: Other Relevant HX: Other:
2824151 72 M MT 02/03/2025 VARZOS
VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
 4LP5Y
4LP5Y
Erythema multiforme, Injection site rash, Pruritus, Rash, Rash pruritic; Skin we... Erythema multiforme, Injection site rash, Pruritus, Rash, Rash pruritic; Skin weeping More
Reported Symptoms: 10015218:ERYTHEMA MULTIFORME; 10023092:ITCHY RASH; 10037087:PRURITUS; 10037844:RA... Reported Symptoms: 10015218:ERYTHEMA MULTIFORME; 10023092:ITCHY RASH; 10037087:PRURITUS; 10037844:RASH; 10074684:RAISED RASH; 10080560:SKIN WEEPING; Narrative: Other Relevant HX: Other: RASH COVERED FROM INJECTION SITE DOWN TO WRIST. VERY ITCHY, RAISED, BUMPS; SOME WHEEPING WHERE BUMPS WERE SCRATCHED. LASTED APPROX 1 WEEK. More
2824152 66 M MT 02/03/2025 FLU3
PNC20
 SANOFI PASTEUR
PFIZER\WYETH
 YF41708
X11327
Lip swelling; Lip swelling Lip swelling; Lip swelling
Reported Symptoms: 10024570:LIP SWELLING; Narrative: Other Relevant HX: Other: Lip Swelling Reported Symptoms: 10024570:LIP SWELLING; Narrative: Other Relevant HX: Other: Lip Swelling
2824153 66 M MT 02/03/2025 PNC13
 PFIZER\WYETH
 X11327
Angioedema, Lip swelling Angioedema, Lip swelling
Reported Symptoms: 10002424:ANGIOEDEMA; 10024570:LIP SWELLING; Narrative: Other Relevant HX: Other: ... Reported Symptoms: 10002424:ANGIOEDEMA; 10024570:LIP SWELLING; Narrative: Other Relevant HX: Other: LIP SWELLING More
2824154 68 M MT 02/03/2025 PPV
PPV
 MERCK & CO. INC.
MERCK & CO. INC.
 N014946
N014946
Angioedema, Cellulitis, Erythema multiforme, Myalgia, Oedema peripheral; Periphe... Angioedema, Cellulitis, Erythema multiforme, Myalgia, Oedema peripheral; Peripheral swelling, Phlebitis, Pruritus, Rash, Skin warm More
Reported Symptoms: 10002424:ANGIOEDEMA; 10015218:ERYTHEMA MULTIFORME; 10034879:PHLEBITIS; 10037087:P... Reported Symptoms: 10002424:ANGIOEDEMA; 10015218:ERYTHEMA MULTIFORME; 10034879:PHLEBITIS; 10037087:PRURITUS; 10037844:RASH; Narrative: Patient had no complications after the vaccine was administered on 1/29/2018 and went home after. Patient then called the clinic, per telemedicine, that same day and reported he had developed increasing increasing generalized pain over his deltoid, triceps, bicep are with warmth and swelling. Patient came into the clinic 1/30/2018 and showed continuous edema in a rectangular area covering now all of his bicep and to a less extent triceps, with no local injection site that could be identified at that time, instead a generalized area of either cellulitis or phlebitis to be developed. No fever chills or other complaints from the patient. Other Relevant HX: Other: More
2824155 F MT 02/03/2025 FLU3
 GLAXOSMITHKLINE BIOLOGICALS
 HS75G
Headache, Pruritus, Rash Headache, Pruritus, Rash
Reported Symptoms: 10037844:RASH; Narrative: Approximately one hour after receiving the flu shot pat... Reported Symptoms: 10037844:RASH; Narrative: Approximately one hour after receiving the flu shot patient developed itchiness to body, and severe headache. Hands and feet very itchy. Patient went to ER for evaluation. Other Relevant HX: Other: RASH More
2824156 71 M MT 02/03/2025 COVID19
 MODERNA
 032B21A
Extra dose administered Extra dose administered
Reported Symptoms: 10064366: EXTRA DOSE ADMINISTERED; Narrative: Patient received first dose of COVI... Reported Symptoms: 10064366: EXTRA DOSE ADMINISTERED; Narrative: Patient received first dose of COVID-19 Moderna vaccine on 02/26/2021, Patient received second dose of COVID-19 Moderna vaccine on 03/20/2021. Patient returned to clinic on 04/17/2021 to receive what he believed was his second dose of COVID-19 vaccine. A third dose of the two dose series was administered prior to the chart being reviewed for appropriateness. When asked for his vaccination card, Patient produced two cards indicating two doses on two different dates had been given as well. These dates were then confirmed through accurate reporting in the patient's chart. Other Relevant HX: Other: Third dose of two dose series given More
2824157 72 M MT 02/03/2025 FLU3
TDAP
 SEQIRUS, INC.
SANOFI PASTEUR
 WT55507
U5489AA
Pruritus, Rash; Pruritus, Rash Pruritus, Rash; Pruritus, Rash
Reported Symptoms: 10037844:RASH; Narrative: whole body rash with itching benadryl was helpful had i... Reported Symptoms: 10037844:RASH; Narrative: whole body rash with itching benadryl was helpful had itching with 2016 vaccine but no rash Other Relevant HX: Other: More
2824160 68 M NV 02/03/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 X3M27/3S354
Asthenia, Chills, Tremor Asthenia, Chills, Tremor
Reported Symptoms: 10008531:CHILLS; 10040527:SHAKINESS; 10047862:WEAKNESS; Narrative: Other Relevant... Reported Symptoms: 10008531:CHILLS; 10040527:SHAKINESS; 10047862:WEAKNESS; Narrative: Other Relevant HX: Other: Shakes, chills, weakness More
2824161 72 M MT 02/03/2025 VARZOS
VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
 2453L
2453L
Injection site cellulitis, Injection site erythema, Injection site induration, I... Injection site cellulitis, Injection site erythema, Injection site induration, Injection site pain, Injection site warmth; Swelling More
Reported Symptoms: 10028411:MYALGIA; 10042674:SWELLING; Narrative: A: 72 y/o male develops mild cell... Reported Symptoms: 10028411:MYALGIA; 10042674:SWELLING; Narrative: A: 72 y/o male develops mild cellulitis in the left deltoid a rea with redness, warm, firm and tenderness 4 x 4 cm, requires pain medication (Patient has tramadol that helps slightly) and antibiotic, need close follow up and return to clinic and also has an appointment on November 14, 2018. Pt states he still has some Tramadol left. P: Keflex 1000 mg PO BID x 10 days, return to outpatient clinic if the conditions gets worse. Other Relevant HX: Patient already had a prescription for tramadol for chronic back pain. Provided did not provide tramadol as a treatment drug, only the antibiotic. Just advised to take the tramadol as prescribed. Other: Swelling More
2824162 78 M MT 02/03/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 539a2
Angioedema, Peripheral swelling Angioedema, Peripheral swelling
Reported Symptoms: 10002424:ANGIOEDEMA; 10002471:ANGIONEUROTIC EDEMA; 10042680:SWELLING ARM; Narrati... Reported Symptoms: 10002424:ANGIOEDEMA; 10002471:ANGIONEUROTIC EDEMA; 10042680:SWELLING ARM; Narrative: Other Relevant HX: Other: angioneurotic edema of larynx, swelling of arm More
2824163 85 M AZ 02/03/2025 COVID19-2
COVID19-2
 PFIZER\BIONTECH
PFIZER\BIONTECH
 GL2042
GL2042
Asthenia, Breakthrough COVID-19, Chest X-ray, Cough, Oropharyngeal pain; Respira... Asthenia, Breakthrough COVID-19, Chest X-ray, Cough, Oropharyngeal pain; Respiratory tract congestion, SARS-CoV-2 test positive More
Reported Symptoms: 10054112:HOSPITALISATON; 10067923:VACCINE BREAKTHROUGH INFECTION; 10084401:COVID-... Reported Symptoms: 10054112:HOSPITALISATON; 10067923:VACCINE BREAKTHROUGH INFECTION; 10084401:COVID-19 RESPIRATORY INFECTION; Narrative: 86 YOM admitted through ED with complain of weakness, cough with congestion and throat pain. ED evaluation confirms COVID positive. Patient treated with remdesivir and discharged to home. Other relevant HX: HTN, Permanent A-Fib, recent CVA 5/24, T2DM, HF Other: Hospitalization for treatment of Covid infection s/p vaccination More
✓
2824164 35 M AZ 02/03/2025 COVID19
COVID19
COVID19
 MODERNA
MODERNA
MODERNA
 004M20A
004M20A
004M20A
Abdominal pain upper, Breakthrough COVID-19, Chest X-ray, Chills, Computerised t... Abdominal pain upper, Breakthrough COVID-19, Chest X-ray, Chills, Computerised tomogram abdomen; Cough, Haematemesis, Nausea, SARS-CoV-2 test positive, Vomiting; Wheezing More
Reported Symptoms: 10054112:HOSPITALISATION; 10067923:VACCINE BREAKTHROUGH INFECTION; 10084401:COVID... Reported Symptoms: 10054112:HOSPITALISATION; 10067923:VACCINE BREAKTHROUGH INFECTION; 10084401:COVID-19 RESPIRATORY INFECTION; Narrative: 39 YOM presented to the ED for evaluation of worsening epigastric pain with associated nausea, vomiting, and coffee-ground emesis that started 2 - 3 days ago. Initial incidental finding of Covid, but patient became symptomatic with bilateral wheezing, chills and cough on second day of hospitalization. Began treatment with remdesivir and dexamethasone. Patient discharged to continue treatment for mental health. Other Relevant HX: PMhx of bipolar disorder, alcohol use, substance use and homelessness Other: Hospitalization for treatment of Covid infection s/p vaccination More
✓
2824165 46 F PA 02/03/2025 FLU3
 GLAXOSMITHKLINE BIOLOGICALS
 7554T
Erythema, Feeling hot, Pruritus Erythema, Feeling hot, Pruritus
Reported Symptoms: 10015150:ERYTHEMA; 10016357:FEELING OF WARMTH; 10037087:PRURITUS; Narrative: Pati... Reported Symptoms: 10015150:ERYTHEMA; 10016357:FEELING OF WARMTH; 10037087:PRURITUS; Narrative: Patient is a 47 year old female who came to the clinic for follow-up for chronic conditions including but not limited to Environmental allergies, obesity, fatty liver, and hematuria. Patient received seasonal influenza vaccine during nurse visit and when being seen by provider complained of pruritis, erythema, and warmth to area. Provider diagnosed as mild allergic reaction to the vaccine and recommended IM injection of Benadryl which patient refused. Provider noted that symptoms were improved/resolved prior to patient leaving clinic and patient was counseled to take benadryl as needed or starting cetirizine for other environmental allergies/rhinitis that they were being seen for. Other Relevant HX: Other: PRURITIS; ERYTHEMA, WARMTH More
2824166 M TX 02/03/2025 COVID19
 PFIZER\BIONTECH
Diarrhoea, Dizziness Diarrhoea, Dizziness
Reported Symptoms: 10012727:DIARRHEA; 10016379:FELT FAINT; Narrative: Other Relevant HX: Other: FEEL... Reported Symptoms: 10012727:DIARRHEA; 10016379:FELT FAINT; Narrative: Other Relevant HX: Other: FEELING FAINT; DIARRHEA More
2824167 70 M FL 02/03/2025 COVID19
 MODERNA
 058H21A
Pain in extremity Pain in extremity
Reported Symptoms: 10033446:PAIN IN LEG; Narrative: Other relevant HX: PAIN IN LEG Reported Symptoms: 10033446:PAIN IN LEG; Narrative: Other relevant HX: PAIN IN LEG
2824168 M TX 02/03/2025 COVID19
 PFIZER\BIONTECH
Anaphylactic reaction Anaphylactic reaction
Reported Symptoms: 10002218:ANAPHYLAXIS; Narrative: Other Relevant HX: Other: ANAPHYLAXIS Reported Symptoms: 10002218:ANAPHYLAXIS; Narrative: Other Relevant HX: Other: ANAPHYLAXIS
📋 Privacy Policy & Data Disclaimer